202 related articles for article (PubMed ID: 11476729)
1. Vasopressin V2 receptor antagonists.
Wong LL; Verbalis JG
Cardiovasc Res; 2001 Aug; 51(3):391-402. PubMed ID: 11476729
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin V2 receptor antagonists.
Verbalis JG
J Mol Endocrinol; 2002 Aug; 29(1):1-9. PubMed ID: 12200224
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Gassanov N; Semmo N; Semmo M; Nia AM; Fuhr U; Er F
Eur J Clin Pharmacol; 2011 Apr; 67(4):333-346. PubMed ID: 21327910
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin dysregulation and hyponatremia in hospitalized patients.
Multz AS
J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
[TBL] [Abstract][Full Text] [Related]
6. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
7. The role of V2 vasopressin antagonists in hyponatremia.
Palm C; Reimann D; Gross P
Cardiovasc Res; 2001 Aug; 51(3):403-8. PubMed ID: 11476730
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
9. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
Urso C; Brucculeri S; Caimi G
J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
[TBL] [Abstract][Full Text] [Related]
10. Water in health and disease: new aspects of disturbances in water metabolism.
Peters HP; Robben JH; Deen PM; Wetzels JF
Neth J Med; 2007 Oct; 65(9):325-32. PubMed ID: 17954951
[TBL] [Abstract][Full Text] [Related]
11. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
12. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
13. Hyponatremia and antidiuresis syndrome.
Vantyghem MC; Balavoine AS; Wémeau JL; Douillard C
Ann Endocrinol (Paris); 2011 Dec; 72(6):500-12. PubMed ID: 22119069
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion.
Tanemoto M
Int Urol Nephrol; 2024 Jan; 56(1):361-362. PubMed ID: 37219713
[No Abstract] [Full Text] [Related]
15. Pediatric disorders of water balance.
Ranadive SA; Rosenthal SM
Pediatr Clin North Am; 2011 Oct; 58(5):1271-80, xi-xii. PubMed ID: 21981960
[TBL] [Abstract][Full Text] [Related]
16. Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options.
Siragy HM
Endocr Pract; 2006; 12(4):446-57. PubMed ID: 16901803
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin antagonists: role in the management of hyponatremia.
Yeates KE; Morton AR
Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin-receptor antagonists: a new class of agents for the treatment of hyponatremia.
Olson BR
Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):249-58. PubMed ID: 17017976
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Palm C; Pistrosch F; Herbrig K; Gross P
Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
Serradeil-Le Gal C
Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
